Premature ventricular contraction medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Premature ventricular contraction}} {{CMG}}; {{AE}} {{M.P}} ==Overview== Isolated premature ventricular contractions with benign characteristics require no treat..." |
No edit summary |
||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
*Pharmacological agents | *Pharmacological agents | ||
**[[Antiarrhythmics]]: these agents alter the electrophysiologic mechanisms responsible for PVCs | **[[Antiarrhythmics]]: these agents alter the electrophysiologic mechanisms responsible for PVCs. | ||
**[[Beta blocker]] : [[Propranolol]], [[atenolol]], [[metoprolol]] | **[[Beta blocker]] : [[Propranolol]], [[atenolol]], [[metoprolol]] | ||
**[[Calcium channel blockers]] | **[[Calcium channel blockers]] | ||
| Line 15: | Line 16: | ||
**Magnesium supplements (e.g. magnesium citrate, orotate, Maalox, etc.) | **Magnesium supplements (e.g. magnesium citrate, orotate, Maalox, etc.) | ||
**Potassium supplements | **Potassium supplements | ||
In the setting of existing cardiac disease, however, PVCs must be watched carefully, as they may cause a form of [[ventricular tachycardia]] (rapid heartbeat). | |||
==References== | ==References== | ||
Revision as of 00:24, 29 August 2013
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction medical therapy On the Web |
|
Premature ventricular contraction medical therapy in the news |
|
to Hospitals Treating Premature ventricular contraction medical therapy |
|
Risk calculators and risk factors for Premature ventricular contraction medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Isolated premature ventricular contractions with benign characteristics require no treatment. In healthy individuals, PVCs can often be resolved by restoring the balance of magnesium, calcium and potassium within the body.
Medical Therapy
- Pharmacological agents
- Antiarrhythmics: these agents alter the electrophysiologic mechanisms responsible for PVCs.
- Beta blocker : Propranolol, atenolol, metoprolol
- Calcium channel blockers
- Electrolytes replacement
- Magnesium supplements (e.g. magnesium citrate, orotate, Maalox, etc.)
- Potassium supplements
In the setting of existing cardiac disease, however, PVCs must be watched carefully, as they may cause a form of ventricular tachycardia (rapid heartbeat).